Medizinische Hochschule Hannover

Academic/Hospital

Also known as: Medizinische Hochschule Hannover, Germany, Prof. Dr. Arndt Vogel | Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie & Endokrinologie

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Jun 14, 2018

Last known activity

Jan 31, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (7 distinct, 3 trials)

Phase 2 (7 own, 0 via acquisition)

gemcitabine
nivolumab
pembrolizumab
lenvatinib
trastuzumab
cisplatin
chlorotrianisene

Indications

Studied for

Carcinoma
Carcinoma, Hepatocellular
Liver Neoplasms

Recent trials (4)

NCT06178445CollaboratorPhase 2Jan 31, 2024
NCT05101629CollaboratorPhase 2Dec 31, 2021
NCT03572582Overall official - principal investigatorPhase 2Jun 14, 2018
NCT03572582OfficialPhase 2Jun 14, 2018

Details

Last known activity: Jan 31, 2024